Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the aesthetic improvement and onset of QM1114-DP treatment for subjects with moderate to severe glabellar lines
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Galderma R&D
NCT05481931 · Glabellar Frown Lines
NCT03985982 · Glabellar Frown Lines
NCT06411002 · Glabellar Frown Lines
NCT05894109 · Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin, Zinc Supplementation for Botulinum Toxin Treatment of the Forehead, and more
NCT05148000 · Glabellar Frown Lines, Canthal Lines
Galderma Research Site
Homewood, Alabama
Galderma Research Site
Manhattan Beach, California
Galderma Research Site
Vista, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions